Dr. Johnsee Lee observes the survival challenges of biotech industry in Taiwan among the global intense competitors (Part One).
After viewing the tremendous experiences of Dr. Johnsee Lee (李鍾熙), the Honorary Director of Taiwan Bio Industry Organization, I believe he is the most suitable candidate to provide advises on the tasks and challenges the biotech industry in Taiwan now faces. GeneOnline is honored to have the opportunity to interview Dr. Lee at the beginning of 2016, and to have him talk about the development of the global biotech industry and the forecast of the Taiwan biomedical industry, hoping that we can find our standpoint in the global market through his penetrating analysis and point of views.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02